false
Catalog
The OUD Cascade of Care: Tailoring Pathways for Bu ...
Presentation
Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the video presentation titled "The OUD Cascade of Care Tailoring Pathways for Buprenorphine Treatment," Dr. Arthur Robin Williams discusses the importance of tailoring care pathways for patients receiving buprenorphine treatment for opioid use disorder (OUD). He highlights the significance of early engagement in treatment, the impact of buprenorphine use at treatment entry on retention, and the predictive value of sustained opioid cessation for long-term retention. Dr. Williams emphasizes the need to identify higher-risk patients and provide enhanced services, such as higher buprenorphine dosing and care coordination. At the six-month mark in care, patients who have achieved opioid cessation are more likely to stay in treatment, and streamlined care should be prioritized for these individuals. Contingency management and adjunctive medications may also be beneficial in supporting patients' treatment journeys. Dr. Williams stresses the importance of personalized care tailored to individual risk profiles to optimize treatment outcomes for patients with OUD.
Keywords
Substance Use
Primary Care
Screening Tools
Implementation Guidance
Medical Settings
TAPS Tool
US Preventive Services Task Force
Electronic Health Records
Referral and Treatment Options
OUD Cascade of Care
Buprenorphine Treatment
Tailoring Care Pathways
Opioid Use Disorder
Early Engagement in Treatment
Buprenorphine Use
Sustained Opioid Cessation
Higher-Risk Patients
Personalized Care
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English